Supplemental Table 1: Cutaneous squamous cell carcinoma tumor accrual rates in immunosuppressed patients with autoimmune and inflammatory conditions; a retrospective cohort study

Published: 13 November 2023| Version 1 | DOI: 10.17632/hhwsdm8vsh.1
Contributors:
Emily Granger, Emily Ruiz, Emily Karn, Morgan Groover

Description

The association of systemic medication exposure with mean tumor accrual rate in immunosuppressed patients relative to immunocompetent controls

Files

Steps to reproduce

Retrospective cohort study; medical record chart review; analysis with STATA, version 17 (StataCorp)

Institutions

Brigham and Women's Hospital, Harvard Medical School

Categories

Oncology, Autoimmune Disorder, Immunosuppression, Squamous Cell Carcinoma, Inflammatory Disorder

Licence